Detalhe da pesquisa
1.
High-Throughput Antigen Microarray Identifies Longitudinal Prognostic Autoantibody for Chemoimmunotherapy in Advanced Non-Small Cell Lung Cancer.
Mol Cell Proteomics
; 23(5): 100749, 2024 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38513890
2.
Longitudinal plasma proteomic analysis identifies biomarkers and combinational targets for anti-PD1-resistant cancer patients.
Cancer Immunol Immunother
; 73(3): 47, 2024 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38349411
3.
Development and validation of a novel risk stratification model and a survival rate calculator for diffuse large B-cell lymphoma in the rituximab era: a multi-institutional cohort study.
Ann Hematol
; 103(1): 211-226, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37861735
4.
Efficacy and safety of PD-1 monoclonal antibody plus rituximab in relapsed/refractory diffuse large B cell lymphoma patients.
Eur J Haematol
; 111(3): 356-364, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37294015
5.
Anti-PD1/PDL1 IgG subclass distribution in ten cancer types and anti-PD1 IgG4 as biomarker for the long time survival in NSCLC with anti-PD1 therapy.
Cancer Immunol Immunother
; 71(7): 1681-1691, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34817638
6.
Enhancement of the International prognostic index with ß2-microglobulin, platelet count and red blood cell distribution width: a new prognostic model for diffuse large B-cell lymphoma in the rituximab era.
BMC Cancer
; 22(1): 583, 2022 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35624433
7.
Prognostic role of red blood cell distribution width and platelet/lymphocyte ratio in early-stage classical Hodgkin lymphoma.
Future Oncol
; 18(15): 1817-1827, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35179068
8.
Low CCL19 expression is associated with adverse clinical outcomes for follicular lymphoma patients treated with chemoimmunotherapy.
J Transl Med
; 19(1): 399, 2021 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34544443
9.
Molecular profiling of Chinese R-CHOP treated DLBCL patients: Identifying a high-risk subgroup.
Int J Cancer
; 147(9): 2611-2620, 2020 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32399964
10.
Abnormal pretreatment coagulation factor levels correlate with poor prognosis in patients with early-stage extranodal nasal-type natural/killer T cell lymphoma.
Ann Hematol
; 99(6): 1303-1309, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32333152
11.
Event-free survival at 24 months is a robust surrogate endpoint for long-term survival in pediatric, adolescent, and adult T cell lymphoblastic lymphoma.
Ann Hematol
; 99(12): 2847-2857, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32712792
12.
Prognostic Nomogram for Overall Survival in Patients with Diffuse Large B-Cell Lymphoma.
Oncologist
; 24(11): e1251-e1261, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30952824
13.
Tracking longitudinal genetic changes of circulating tumor DNA (ctDNA) in advanced Lung adenocarcinoma treated with chemotherapy.
J Transl Med
; 17(1): 339, 2019 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31597567
14.
Clinical features and outcomes of diffuse large B-cell lymphoma based on nodal or extranodal primary sites of origin: Analysis of 1,085 WHO classified cases in a single institution in China.
Chin J Cancer Res
; 31(1): 152-161, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30996573
15.
Gemcitabine, dexamethasone, and cisplatin (GDP) as salvage chemotherapy for patients with relapsed or refractory peripheral T cell lymphoma-not otherwise specified.
Ann Hematol
; 96(2): 245-251, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27858107
16.
Intensity-modulated radiation therapy followed by GDP chemotherapy for newly diagnosed stage I/II extranodal natural killer/T cell lymphoma, nasal type.
Ann Hematol
; 96(9): 1477-1483, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28695246
17.
[Duration of filgrastim prophylaxis for chemotherapy-induced neutropenia and its predictors].
Zhonghua Zhong Liu Za Zhi
; 38(1): 69-72, 2016 Jan.
Artigo
em Zh
| MEDLINE | ID: mdl-26796810
18.
Phase I study of chimeric anti-CD20 monoclonal antibody in Chinese patients with CD20-positive non-Hodgkin's lymphoma.
Chin J Cancer Res
; 28(2): 197-208, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27199517
19.
[Efficacy and safety evaluation of gemcitabine combined with ifosfamide in patients with advanced nasopharyngeal carcinoma after failure of platinum-based chemotherapy].
Zhonghua Zhong Liu Za Zhi
; 37(8): 632-6, 2015 Aug.
Artigo
em Zh
| MEDLINE | ID: mdl-26714607
20.
Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin's lymphoma.
Chin J Cancer
; 34(11): 522-30, 2015 Sep 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-26370464